An allergic reaction to drugs is no stranger to man or beast, and it has long been recognised that rough collies are particula
An allergic reaction to drugs is no stranger to man or beast, and it has long
been recognised that Rough Collies are particularly sensitive to a range of
sedatives, tranquillisers and anaesthetics, although many in the veterinary
profession have and continue to pour scorn on such claims.
Early in the 1980s a new class of anti-parasitic preparations for large
animals, based on the active ingredient ivermectin, became available for
general veterinary use and although not licensed for use on dogs veterinary
practitioners were not slow in discovering its usefulness when treating
persistent cases of parasitic infestations, so that it quickly became the drug
of choice especially when mange was diagnosed.
Shortly after Ivermectin’s introduction to the veterinary armoury rumours
began to circulate about its adverse side-effects when administered to
Rough Collies. When a well known Italian breeder lost four of her valuable
Rough Collies after an Ivermectin based drug was administered as a wide
spectrum anti-parasitic preventative to her kennel suspicions became facts
which were widely circulated by breeders throughout the world. However
the veterinary profession as a whole remained sceptical despite Merck Sharp
and Dohme Ltd [MSD], who manufactured the drug used in the Italian case,
issuing the following advice — ‘Ivermectin is known to have an adverse effect on certain breeds of dog’ — in three letters written to the editor of
‘The Veterinary Record’. A more detailed warning included in the drug’s
packaging was not introduced until after at least one more serious breeding
As the number of breeds reporting adverse reactions increased and
additional drugs, several of which were licensed for canine use, were added
to the list of suspect preparations two groups of veterinary scientists began
investigating the origin of this apparent problem. Early observations showed
affected dogs had an elevated concentration of the offending substance in
their central nervous system, when this fact was linked to the discover that
genetically modified laboratory mice, being used in quite independent
research into the necessity of the Multi Drug Resistance-1 [MDR-1] gene,
quickly died when treated with an ‘Ivermectin’ based spray for a mite
infestation, the American based team, headed by Dr Katrina Mealey and Dr
Mark Neff, gained the necessary breakthrough in isolate the cause of this
In order to take this research forward a DNA test was perfected, with swabs
collected internationally from a wide selection of apparently unrelated
breeds, mostly pastoral and hounds, which had reported some incidence of
drug sensitivity. Once analysed the results revealed a pre-existing mutation
of the MDR-1 gene in the wider Collie family, possibly dated early to mid
nineteenth century, which confirmed what many Collie enthusiasts had long
A large number of drugs are known to be controlled by the MDR-1 gene in
man although there is insufficient data available to be specific about the
way these drugs may affect dogs carrying the double mutant (-/-) MDR-1
gene, but it is now recognised that more than fifty substances are known,
suspected, or have the potential to cause problems with these dogs and this
list is being extended almost daily. These drugs, although not necessarily
licensed for dogs in the UK, are used to treat a wide spectrum of canine
ailments including cancer, heart disease and pain relief, in addition to anti-
parasitic and anti-histamines preparations which sparked off the original
The American research team’s findings were published as recently as 2004,
and the DNA test perfected by the research team made available, in both
America and Europe, during 2007, therefore the significance of the MDR-1
mutation has yet to be fully evaluated. There are those who believe that
this is far in excess of currently accepted knowledge, sighting the fact that
when given as a cocktail of drugs the effects are far more serious, while
others prefer to deny its relevance. Whatever your belief the knowledge
that a DNA test exists can only assist veterinarians in their choice of
treatment options, this of greatest importance when deciding the treatment
for more serious conditions such as cancer and heart disease.
The European scientific team working in Germany are still actively
investigating the effects of abnormalities in the Multi Drug Resistance gene
complex, together with its production of P-glycoprotein, on humans and it is
believed that their finding will also apply to the canine species, but time is
required before speculative theory can be translated into irrefutable fact.
Until this happens breeders are urged to DNA test all breeding stock, taking
the results into consideration when choosing a suitable mate, and owners
are encouraged to insist that their veterinary advisors not only add their
pet’s genetic MDR-1 status to their medical records, but to also fully
research the problem before treating any Collie related animal.
The Rough Collie Breed Council, on behalf of its Member Clubs, would like
to assure all owners of affected breeds that even those graded double
negative [-/-] after a DNA test regularly live long happy healthy lives. The
side effects of this drug sensitivity not surfacing until one of the problem
drugs are administered for an unrelated health condition, the solution is to
avoid these drugs which is perfectly possible.
International Task Force for Prevention Of Coronary Heart Disease Coronary heart disease and stroke: Risk factors and global risk Slide Kit 1 Primary prevention of stroke International Task Force for Prevention of Coronary Heart DiseaseStrokeSlide Kit 1:Primary prevention of stroke T A B LE OF CON T E N T Primary prevention of ischemic stroke. Recommendations for risk f
Utility Profile: Commonwealth Edison (Exelon) Smart Grid Program Overview Successful, state-mandated AMI pilot provided results to justify total-footprint deployment based on operational savings alone; AMI-enabled pilot testing TOU, CPP, PTR, and RTP Utility Type: IOU DR: Pricing, with varying technologies; RTP offer available to all customers Multiple Rates Size: 3,800